Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting neuromuscular diseases, announced multiple major milestones for ATA-100 and ATA-200,...
ReCode Therapeutics, a biopharmaceutical company powering the next wave of genetic medicines through superior delivery presented new preclinical data from the company’s inhaled mRNA-based...
The digital transformation has already begun. Businesses in all industries are using technology to change and improve how they operate and serve their customers....
Rejuvenate Biomed NV, a biomedical company developing novel combination drugs for age-related diseases, appoints Dr. Ajit Shetty as Chair of the Board of Directors....
CANbridge Pharmaceuticals, Inc., a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced...
